Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

CD8 T cells express randomly selected KIRs with distinct specificities compared with NK cells.

Björkström NK, Béziat V, Cichocki F, Liu LL, Levine J, Larsson S, Koup RA, Anderson SK, Ljunggren HG, Malmberg KJ.

Blood. 2012 Oct 25;120(17):3455-65. doi: 10.1182/blood-2012-03-416867. Epub 2012 Sep 11.

2.

KIR acquisition probabilities are independent of self-HLA class I ligands and increase with cellular KIR expression.

Andersson S, Fauriat C, Malmberg JA, Ljunggren HG, Malmberg KJ.

Blood. 2009 Jul 2;114(1):95-104. doi: 10.1182/blood-2008-10-184549. Epub 2009 Mar 20.

3.

NK-KIR transcript kinetics correlate with acute graft-versus-host disease occurrence after allogeneic bone marrow transplantation.

Denis L, Gagne K, Gueglio B, Kerdudou N, Milpied N, Simon P, Follea G, Bonneville M, Harousseau JL, Bignon JD.

Hum Immunol. 2005 May;66(5):447-59. Epub 2005 Feb 19.

PMID:
15935882
4.

NK cell killer Ig-like receptor repertoire acquisition and maturation are strongly modulated by HLA class I molecules.

Sleiman M, Brons NH, Kaoma T, Dogu F, Villa-Forte A, Lenoble P, Hentges F, Kotsch K, Gadola SD, Vilches C, Zimmer J.

J Immunol. 2014 Mar 15;192(6):2602-10. doi: 10.4049/jimmunol.1302843. Epub 2014 Feb 19.

5.

Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.

Yu J, Heller G, Chewning J, Kim S, Yokoyama WM, Hsu KC.

J Immunol. 2007 Nov 1;179(9):5977-89. Erratum in: J Immunol. 2007 Dec 15;179(12):8570.

6.

Receptor systems controlling natural killer cell function are genetically stratified in Europe.

Guinan KJ, Cunningham RT, Meenagh A, Dring MM, Middleton D, Gardiner CM.

Genes Immun. 2010 Jan;11(1):67-78. doi: 10.1038/gene.2009.60. Epub 2009 Aug 20.

PMID:
19693090
7.

NK cells expressing inhibitory KIR for non-self-ligands remain tolerant in HLA-matched sibling stem cell transplantation.

Björklund AT, Schaffer M, Fauriat C, Ringdén O, Remberger M, Hammarstedt C, Barrett AJ, Ljungman P, Ljunggren HG, Malmberg KJ.

Blood. 2010 Apr 1;115(13):2686-94. doi: 10.1182/blood-2009-07-229740. Epub 2010 Jan 22.

8.

Study of KIR expression and HLA ligands in CD56+ lymphocytes of drug resistant tuberculosis patients.

Mousavi T, Shahsavar F, Farnia P, Tajik N, Soofi M.

Iran J Allergy Asthma Immunol. 2011 Sep;10(3):189-94. doi: 010.03/ijaai.189194.

9.

Neonatal NK-cell repertoires are functionally, but not structurally, biased toward recognition of self HLA class I.

Schönberg K, Fischer JC, Kögler G, Uhrberg M.

Blood. 2011 May 12;117(19):5152-6. doi: 10.1182/blood-2011-02-334441. Epub 2011 Mar 17.

10.

Bridging innate NK cell functions with adaptive immunity.

Marcenaro E, Carlomagno S, Pesce S, Moretta A, Sivori S.

Adv Exp Med Biol. 2011;780:45-55. doi: 10.1007/978-1-4419-5632-3_5. Review.

PMID:
21842364
11.

Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells.

Igarashi T, Wynberg J, Srinivasan R, Becknell B, McCoy JP Jr, Takahashi Y, Suffredini DA, Linehan WM, Caligiuri MA, Childs RW.

Blood. 2004 Jul 1;104(1):170-7. Epub 2004 Mar 11.

12.

Killer immunoglobulin-like receptor transcriptional regulation: a fascinating dance of multiple promoters.

Cichocki F, Miller JS, Anderson SK.

J Innate Immun. 2011;3(3):242-8. doi: 10.1159/000323929. Epub 2011 Mar 11. Review.

13.

Coordinated expression of Ig-like inhibitory MHC class I receptors and acquisition of cytotoxic function in human CD8+ T cells.

Anfossi N, Doisne JM, Peyrat MA, Ugolini S, Bonnaud O, Bossy D, Pitard V, Merville P, Moreau JF, Delfraissy JF, Dechanet-Merville J, Bonneville M, Venet A, Vivier E.

J Immunol. 2004 Dec 15;173(12):7223-9.

14.
15.

Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation.

Shilling HG, McQueen KL, Cheng NW, Shizuru JA, Negrin RS, Parham P.

Blood. 2003 May 1;101(9):3730-40. Epub 2003 Jan 2.

16.

Self-tolerance of human natural killer cells lacking self-HLA-specific inhibitory receptors.

Hasenkamp J, Borgerding A, Uhrberg M, Falk C, Chapuy B, Wulf G, Jung W, Trümper L, Glass B.

Scand J Immunol. 2008 Mar;67(3):218-29. doi: 10.1111/j.1365-3083.2007.02058.x. Epub 2008 Jan 22.

17.

Natural killer (NK) cell receptors' repertoire in couples with recurrent spontaneous abortions.

Varla-Leftherioti M, Spyropoulou-Vlachou M, Niokou D, Keramitsoglou T, Darlamitsou A, Tsekoura C, Papadimitropoulos M, Lepage V, Balafoutas C, Stavropoulos-Giokas C.

Am J Reprod Immunol. 2003 Mar;49(3):183-91.

PMID:
12797525
18.

Activating killer immunoglobulin-like receptor incompatibilities enhance graft-versus-host disease and affect survival after allogeneic hematopoietic stem cell transplantation.

Giebel S, Nowak I, Dziaczkowska J, Czerw T, Wojnar J, Krawczyk-Kulis M, Holowiecki J, Holowiecka-Goral A, Markiewicz M, Kopera M, Karolczyk A, Kyrcz-Krzemien S, Kusnierczyk P.

Eur J Haematol. 2009 Oct;83(4):343-56. doi: 10.1111/j.1600-0609.2009.01280.x. Epub 2009 Jun 2.

PMID:
19500138
19.

Expression of the HLA-C2-specific activating killer-cell Ig-like receptor KIR2DS1 on NK and T cells.

Cognet C, Farnarier C, Gauthier L, Frassati C, André P, Magérus-Chatinet A, Anfossi N, Rieux-Laucat F, Vivier E, Schleinitz N.

Clin Immunol. 2010 Apr;135(1):26-32. doi: 10.1016/j.clim.2009.12.009. Epub 2010 Jan 25.

PMID:
20093094
20.

Divergences in KIR2D+ natural killer and KIR2D+CD8+ T-cell reconstitution following liver transplantation.

López-Álvarez MR, Campillo JA, Legaz I, Blanco-García RM, Salgado-Cecilia G, Bolarín JM, Gimeno L, Gil J, García-Alonso AM, Muro M, Alvarez-López MR, Miras M, Minguela A.

Hum Immunol. 2011 Mar;72(3):229-37. doi: 10.1016/j.humimm.2010.12.015. Epub 2011 Jan 4.

PMID:
21215286

Supplemental Content

Support Center